查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1810977

2025年新型藥物輸送系統全球市場報告

Novel Drug Delivery Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

新型藥物輸送系統市場預計將在未來幾年強勁成長，到 2029 年將達到 1,710.2 億美元，年複合成長率（CAGR）為 9.8%。預測期內的成長可以歸因於以下因素：全球對疫情預防的關注度不斷提高、對快速和有針對性的藥物輸送的需求不斷成長、抗菌素管理意識的不斷提高、更嚴格的環境和包裝法規有利於控制輸送方法，以及醫藥創新領域官民合作關係的不斷加強。這段時期的主要趨勢包括奈米載體和乳化的應用、可生物分解和刺激響應材料的開發、3D 列印在個人化劑型中的應用日益廣泛、經皮和微針技術的進步以及人工智慧在製劑設計中的應用。

神經系統疾病發生率的不斷上升預計將推動新型藥物傳輸系統市場的成長。中風等神經系統疾病是指因腦血流受阻（缺血性中風）或血管破裂（出血性中風）而導致神經功能突然喪失，從而造成腦損傷以及認知、感覺和運動方面的長期障礙。人口老化、高血壓、糖尿病和肥胖等文明病的增加以及慢性壓力和環境風險的增加等因素導致了神經病變的增加。新型藥物輸送系統可以透過跨血腦障壁提供標靶化和可控的藥物輸送來幫助治療這些疾病。例如，2024 年 11 月，英國國家醫療服務體系 (NHS) 報告稱，2023/24 年英國住院中風患者人數將達到 111,137 人，其中 50-59 歲年齡層增幅最大，將新增 12,533 例。因此，神經系統疾病的盛行率不斷上升，刺激了新型藥物傳輸系統市場的發展。

新型藥物輸送系統市場的主要企業正在透過口腔薄膜等產品進行創新，以提高患者的依從性和治療效果。口腔薄膜是一種即溶貼片，貼於口腔，可將藥物透過黏膜直接輸送到血液中。例如，2024年2月，美國製藥製劑公司CD Formulation推出了其口腔薄膜技術。該技術可繞過胃腸道和肝臟代謝，實現藥物的快速吸收，是吞嚥困難患者的理想選擇。此外，該技術還能達到精準給藥和快速起效，進而提高多種治療的精準度和便利性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球新型藥物輸送系統：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球新型藥物輸送系統市場：成長率分析
  • 全球新型藥物輸送系統市場表現：規模與成長，2019-2024
  • 全球新型藥物輸送系統市場預測：規模與成長，2024-2029 年，2034 年
  • 全球新型藥物輸送系統：總目標市場（TAM）

第6章市場區隔

  • 全球新型藥物輸送系統市場（按製劑類型、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • 脂質體
  • 奈米粒子
  • 微球
  • 水凝膠
  • 樹狀聚合物
  • 全球新型藥物輸送系統市場：新型藥物輸送系統 (NDDS) 的模式、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 標靶藥物傳輸系統
  • 受管制藥物傳輸系統
  • 受管制藥物傳輸系統
  • 全球新型藥物輸送系統市場：按途徑、實際狀況及預測，2019-2024 年、2024-2029 年、2034 年
  • 口服給藥系統
  • 注射藥物輸送系統
  • 肺部給藥系統
  • 經皮藥物輸送系統
  • 其他路線
  • 全球新型藥物輸送系統市場：依治療領域、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 心血管疾病
  • 神經系統疾病
  • 感染疾病
  • 自體免疫疾病
  • 全球新型藥物輸送系統市場：依最終用戶、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所
  • 研究中心
  • 其他最終用戶
  • 全球新型藥物傳輸系統市場：脂質體細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 聚乙二醇化脂質體
  • 陽離子脂質體
  • 隱形脂質體
  • 免疫脂質體
  • 全球新型藥物傳輸系統市場：按奈米顆粒類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 聚合物奈米粒子
  • 脂質奈米顆粒
  • 金屬奈米粒子
  • 奈米晶體
  • 全球新型藥物輸送系統市場：按微球類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 可生物分解微球
  • 磁性微球
  • 放射性微球
  • 黏膜黏附微球
  • 全球新型藥物傳輸系統市場：水凝膠細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 溫敏水凝膠
  • pH響應性水凝膠
  • 可注射水凝膠
  • 智慧水凝膠
  • 全球新型藥物輸送系統市場：依樹狀聚合物類型細分、實際結果及預測（2019-2024 年、2024-2029 年及 2034 年）
  • PAMAM樹狀聚合物
  • PPI樹狀聚合物
  • 聚乙二醇化樹狀聚合物
  • 混合樹狀聚合物

第7章 區域和國家分析

  • 全球新型藥物輸送系統市場：按地區、結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球新型藥物輸送系統市場：依國家、實際結果及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 新型藥物輸送系統市場：競爭格局
  • 新型藥物輸送系統市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Bayer AG
  • Sanofi SA
  • Bristol-Myers Squibb Company
  • Thermo Fisher Scientific Company
  • AstraZeneca PLC
  • Abbott Laboratories
  • Novartis AG
  • GlaxoSmithKline PLC（GSK）
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Gilead Sciences
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Boston Scientific Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年新型藥物輸送系統市場：提供新機會的國家
  • 2029年新型藥物輸送系統市場：提供新機會的細分市場
  • 2029年新型藥物輸送系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r37079

Novel drug delivery systems are advanced pharmaceutical technologies aimed at improving the effectiveness, safety, bioavailability, and targeted delivery of medications by precisely controlling the rate, timing, and location of drug release in the body. These systems address the shortcomings of traditional delivery methods, enhance treatment outcomes, and boost patient adherence across diverse medical and therapeutic fields.

Key formulation types within novel drug delivery systems include liposomes, nanoparticles, microspheres, hydrogels, and dendrimers. Liposomes are spherical vesicles made of phospholipid bilayers that encapsulate drugs, allowing for targeted delivery, controlled release, and minimized drug toxicity. The delivery modes include targeted, controlled, and modulated drug delivery systems, which are administered through various routes such as oral, injectable, pulmonary, transdermal, and others. These systems are applied in multiple therapeutic areas including cancer, cardiovascular diseases, neurological disorders, infectious diseases, and autoimmune diseases, serving end-users like hospitals, specialty clinics, research centers, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The novel drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides novel drug delivery systems market statistics, including novel drug delivery systems industry global market size, regional shares, competitors with a novel drug delivery systems market share, detailed novel drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the novel drug delivery systems industry. This novel drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The novel drug delivery systems market size has grown rapidly in recent years. It will grow from $106.95 billion in 2024 to $117.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth during the historic period can be linked to the increasing prevalence of chronic diseases, an expanding geriatric population, rising demand for minimally invasive treatments, heightened patient awareness about drug efficacy and safety, and the development of global healthcare infrastructure.

The novel drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $171.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth projected for the forecast period can be attributed to a heightened global emphasis on pandemic preparedness, increased demand for rapid and targeted drug delivery, greater awareness of antimicrobial stewardship, stricter environmental and packaging regulations favoring controlled delivery methods, and expanding public-private partnerships in pharmaceutical innovation. Key trends during this period include the incorporation of nanocarriers and nanoemulsions, development of biodegradable and stimuli-responsive materials, wider use of 3D printing for personalized dosage forms, advancements in transdermal and microneedle technologies, and the adoption of artificial intelligence in formulation design.

The increasing cases of neurological disorders are anticipated to drive growth in the novel drug delivery systems market. Neurological disorders like stroke involve the sudden loss of neurological function caused by interrupted blood flow to the brain, either through a blockage (ischemic stroke) or a blood vessel rupture (hemorrhagic stroke), resulting in brain damage and possible long-term impairments in cognition, sensation, or movement. Factors such as aging populations, the rising prevalence of lifestyle-related conditions including hypertension, diabetes, and obesity, as well as greater exposure to chronic stress and environmental risks, are contributing to the increase in neurological disorders. Novel drug delivery systems aid in treating these disorders by providing targeted and controlled delivery of medications across the blood-brain barrier. For example, in November 2024, the National Health Service (NHS) England reported that stroke admissions in England reached 111,137 in 2023/24, with the highest rise seen in the 50-59 age group, which had 12,533 new cases. Consequently, the growing incidence of neurological disorders is fueling the novel drug delivery systems market.

Leading companies in the novel drug delivery systems market are innovating with products like oral thin films to improve patient compliance and treatment effectiveness. Oral thin films are rapidly dissolving strips applied inside the mouth that deliver drugs directly into the bloodstream through the mucosal lining. For example, in February 2024, CD Formulation, a US pharmaceutical formulation company, introduced Oral Thin Film Technology. This technology enables quick drug absorption by bypassing the gastrointestinal tract and liver metabolism, making it ideal for patients who have difficulty swallowing. It also allows precise dosing and faster onset of effects, enhancing treatment accuracy and convenience across multiple therapies.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical firm, acquired Aveva Drug Delivery Services Inc. for an undisclosed sum. This acquisition is intended to expand DifGen's expertise in complex dosage forms by adding US research and manufacturing capabilities for transdermal and thin film drug delivery systems. Aveva Drug Delivery Services Inc. specializes in transdermal drug delivery and oral dissolvable films.

Major players in the novel drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC (GSK), Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Regeneron Pharmaceuticals, Samyang Holdings Corporation, and Galen Limited.

North America was the largest region in the novel drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in novel drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the novel drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The novel drug delivery systems market consists of sales of implants, micelles, exosomes, prodrugs, nasal drug delivery devices, buccal drug delivery films, and ocular drug delivery inserts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Novel Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on novel drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for novel drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The novel drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Formulation Type: Liposomes; Nanoparticles; Microspheres; Hydrogels; Dendrimers
  • 2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems; Controlled Drug Delivery Systems; Modulated Drug Delivery Systems
  • 3) By Route: Oral Drug Delivery Systems; Injectable Drug Delivery Systems; Pulmonary Drug Delivery Systems; Transdermal Drug Delivery Systems; Other Routes
  • 4) By Therapeutic Area: Cancer; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Autoimmune Diseases
  • 5) By End-User: Hospital; Specialty Clinics; Research Centers; Other End-Users
  • Subsegments:
  • 1) By Liposomes: PEGylated Liposomes; Cationic Liposomes; Stealth Liposomes; Immunoliposomes
  • 2) By Nanoparticles: Polymeric Nanoparticles; Lipid Nanoparticles; Metallic Nanoparticles; Nanocrystals
  • 3) By Microspheres: Biodegradable Microspheres; Magnetic Microspheres; Radioactive Microspheres; Mucoadhesive Microspheres
  • 4) By Hydrogels: Thermosensitive Hydrogels; Ph-Responsive Hydrogels; Injectable Hydrogels; Smart Hydrogels
  • 5) By Dendrimers: PAMAM Dendrimers; PPI Dendrimers; Pegylated Dendrimers; Hybrid Dendrimers
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company; Thermo Fisher Scientific Company; AstraZeneca PLC; Abbott Laboratories; Novartis AG; GlaxoSmithKline PLC (GSK); Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Gilead Sciences; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Co. Ltd.; Boston Scientific Corporation; Regeneron Pharmaceuticals; Samyang Holdings Corporation; Galen Limited.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Novel Drug Delivery Systems Market Characteristics

3. Novel Drug Delivery Systems Market Trends And Strategies

4. Novel Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Novel Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Novel Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Novel Drug Delivery Systems Market Growth Rate Analysis
  • 5.4. Global Novel Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Novel Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Novel Drug Delivery Systems Total Addressable Market (TAM)

6. Novel Drug Delivery Systems Market Segmentation

  • 6.1. Global Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liposomes
  • Nanoparticles
  • Microspheres
  • Hydrogels
  • Dendrimers
  • 6.2. Global Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Drug Delivery Systems
  • Controlled Drug Delivery Systems
  • Modulated Drug Delivery Systems
  • 6.3. Global Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Drug Delivery Systems
  • Injectable Drug Delivery Systems
  • Pulmonary Drug Delivery Systems
  • Transdermal Drug Delivery Systems
  • Other Routes
  • 6.4. Global Novel Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Cardiovascular Diseases
  • Neurological Disorders
  • Infectious Diseases
  • Autoimmune Diseases
  • 6.5. Global Novel Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Specialty Clinics
  • Research Centers
  • Other End-Users
  • 6.6. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PEGylated Liposomes
  • Cationic Liposomes
  • Stealth Liposomes
  • Immunoliposomes
  • 6.7. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymeric Nanoparticles
  • Lipid Nanoparticles
  • Metallic Nanoparticles
  • Nanocrystals
  • 6.8. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Microspheres, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biodegradable Microspheres
  • Magnetic Microspheres
  • Radioactive Microspheres
  • Mucoadhesive Microspheres
  • 6.9. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Hydrogels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Thermosensitive Hydrogels
  • Ph-Responsive Hydrogels
  • Injectable Hydrogels
  • Smart Hydrogels
  • 6.10. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PAMAM Dendrimers
  • PPI Dendrimers
  • Pegylated Dendrimers
  • Hybrid Dendrimers

7. Novel Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Novel Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Novel Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Novel Drug Delivery Systems Market

  • 8.1. Asia-Pacific Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Novel Drug Delivery Systems Market

  • 9.1. China Novel Drug Delivery Systems Market Overview
  • 9.2. China Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Novel Drug Delivery Systems Market

  • 10.1. India Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Novel Drug Delivery Systems Market

  • 11.1. Japan Novel Drug Delivery Systems Market Overview
  • 11.2. Japan Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Novel Drug Delivery Systems Market

  • 12.1. Australia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Novel Drug Delivery Systems Market

  • 13.1. Indonesia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Novel Drug Delivery Systems Market

  • 14.1. South Korea Novel Drug Delivery Systems Market Overview
  • 14.2. South Korea Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Novel Drug Delivery Systems Market

  • 15.1. Western Europe Novel Drug Delivery Systems Market Overview
  • 15.2. Western Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Novel Drug Delivery Systems Market

  • 16.1. UK Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Novel Drug Delivery Systems Market

  • 17.1. Germany Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Novel Drug Delivery Systems Market

  • 18.1. France Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Novel Drug Delivery Systems Market

  • 19.1. Italy Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Novel Drug Delivery Systems Market

  • 20.1. Spain Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Novel Drug Delivery Systems Market

  • 21.1. Eastern Europe Novel Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Novel Drug Delivery Systems Market

  • 22.1. Russia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Novel Drug Delivery Systems Market

  • 23.1. North America Novel Drug Delivery Systems Market Overview
  • 23.2. North America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Novel Drug Delivery Systems Market

  • 24.1. USA Novel Drug Delivery Systems Market Overview
  • 24.2. USA Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Novel Drug Delivery Systems Market

  • 25.1. Canada Novel Drug Delivery Systems Market Overview
  • 25.2. Canada Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Novel Drug Delivery Systems Market

  • 26.1. South America Novel Drug Delivery Systems Market Overview
  • 26.2. South America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Novel Drug Delivery Systems Market

  • 27.1. Brazil Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Novel Drug Delivery Systems Market

  • 28.1. Middle East Novel Drug Delivery Systems Market Overview
  • 28.2. Middle East Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Novel Drug Delivery Systems Market

  • 29.1. Africa Novel Drug Delivery Systems Market Overview
  • 29.2. Africa Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Novel Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Novel Drug Delivery Systems Market Competitive Landscape
  • 30.2. Novel Drug Delivery Systems Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Novel Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Sanofi SA
  • 31.3. Bristol-Myers Squibb Company
  • 31.4. Thermo Fisher Scientific Company
  • 31.5. AstraZeneca PLC
  • 31.6. Abbott Laboratories
  • 31.7. Novartis AG
  • 31.8. GlaxoSmithKline PLC (GSK)
  • 31.9. Takeda Pharmaceutical Company Limited
  • 31.10. Eli Lilly and Company
  • 31.11. Gilead Sciences
  • 31.12. Amgen Inc.
  • 31.13. Teva Pharmaceutical Industries Ltd.
  • 31.14. Otsuka Pharmaceutical Co. Ltd.
  • 31.15. Boston Scientific Corporation

32. Global Novel Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Novel Drug Delivery Systems Market

34. Recent Developments In The Novel Drug Delivery Systems Market

35. Novel Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Novel Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Novel Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Novel Drug Delivery Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer